2022
Digital

DHM Digital 2022, Drug Hypersensitivity Meeting

Update: announcement of DHM Digital 2022

EAACI is glad to announce that the Drug Hypersensitive Meeting 2022 (DHM 2022) is planned to be held in 2022. The final layout will be digitally. After the postponement of the event in 2021, due to the COVID-19 pandemic, we are now confident that the organization of this prestigious EAACI meeting will bring our community the possibility to get the latest updates on the field and benefit from the now well-established expertise our academy has gathered in terms of digital events.

During these challenging times, EAACI believes that only through a strong and close collaboration within our community, we will be able to overcome eventual difficulties and granting the flexibility and possibility to enjoy this EAACI meeting of high quality.

Please stay tuned for more information about registration and abstract submission to be released soon.


If you have any queries, our team at events@eaaci.org will be happy to assist you.

We are looking forward to welcoming you to DHM 2022 in April!

Marek Jutel
EAACI President

Edward Knol
EAACI Vice-President Congresses

EAACI News

Subscribe to the EAACI mailing list to get updated on our latest activities and events by submitting your email below.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel